Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Related on ScholarIQ
Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are chemogenetic tools for remote control of targeted cell populations using chemical actuators that bind to modified receptors. Despite the popularity of DREADDs in neuroscience and sleep research
Author
potential effects of clozapine-N-oxide (CNO) and other DREADD actuators on sleep have never been systematically tested. Recent reports suggest that CNO can affect brain activity and animal behaviour
Author
a novel actuator that cannot convert to clozapine
Author
putatively through conversion to clozapine. The aim of our study was to assess whether CNO or compound 21 (C21)
Author
affect sleep in wild type laboratory mice.
Author
Journal of Sleep Research
Journal